Status:
COMPLETED
Procalcitonin to Guide Obtaining Bloodcultures in the ICU Intensive Care Infection Score
Lead Sponsor:
Erasmus Medical Center
Conditions:
Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
PROBIC Rationale: Procalcitonin measurements can reduce the number of blood cultures in the ICU. Objective: The investigators suggest that PCT is a marker for blood stream infection in all patients ...
Eligibility Criteria
Inclusion
- Patients will need to be over the age of 18 and suffering from an assumed infection deemed clinically worthy for blood culturing.
Exclusion
- Uncontrolled malignancy
- Immunosuppressive or immunostimulatory therapy
- Neutropenia, defined as leukocyte count less then 0.5x109/L
- Moribund patients
- Predetermined illness with an expected death within 24 hours
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
1130 Patients enrolled
Trial Details
Trial ID
NCT01847079
Start Date
January 1 2013
End Date
October 1 2014
Last Update
October 15 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus MC
Rotterdam, South Holland, Netherlands, 3015CE
2
Maasstad Ziekenhuis
Rotterdam, South Holland, Netherlands, 3079DZ